Author

R. Cornell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 3 Research Focus:cell-cell communication· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

C. Kenny· 4 shared E. Steingrimsson· 3 shared L. Larue· 2 shared M. Levesque· 2 shared A. Bellacosa· 1 shared A. Bhinu· 1 shared A. Helverson· 1 shared A. K. Arnadottir· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

C. Kenny

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Antagonistic Roles for MITF and TFE3 in Melanoma Plasticity

J. Chang, K. R. Campbell-Hanson, M. Vanneste, N. I. Bartschat, R. Nagel, A. K. Arnadottir, H. Nhung Vu, C. Montgomery, J. Yevdash, J. Jiarui, A. Bhinu, A. Helverson, M. Henry, E. Steingrimsson, R. J. Weigel, , C. Kenny

This study identifies TFE3 and the non-canonical mTORC1 pathway as regulators of melanoma cell state plasticity, showing MITF suppresses the mesenchymal phenotype by modulating TFE3 expression.

bioRxiv · Jul 11, 2024Cancer Biology

BRN2 is a non-canonical melanoma tumor-suppressor

M. Hamm, P. Sohier, V. Petit, J. Raymond, V. Delmas, M. Le Coz, F. Gesbert, C. Kenny, Z. Aktary, M. Pouteaux, F. Rambow, A. Sarasin, A. Bellacosa, L. Sanchez-del-Campo, L. Mosteo, , L. Larue

This study identifies BRN2 as a non-canonical tumor suppressor in melanoma, showing its role in initiation and progression through PTEN regulation and PI3K signaling.

bioRxiv · Jan 13, 2021Cancer Biology

Cell state diversity promotes metastasis through heterotypic cluster formation in melanoma

N. R. Campbell, A. Rao, X. Zhang, M. Baron, S. Heilmann, M. Deforet, C. Kenny, L. Ferretti, T.-H. Huang, M. Garg, J. Nsengimana, E. Montal, M. Tagore, M. Hunter, J. Newton-Bishop, , R. White

This study shows that melanoma metastasis is promoted by heterotypic clusters formed between proliferative and invasive cell states, mediated by TFAP2.

bioRxiv · Aug 24, 2020 · PreprintCancer Biology

MITF reprograms the extracellular matrix and focal adhesion in melanoma

R. Dilshat, V. Fock, C. Kenny, I. Gerritsen, R. M. J. Lasseur, O. Eichhoff, J. Travnickova, P. Cerny, K. Moller, S. Sigurbjornsdottir, K. Kirty, B. O. Einarsdottir, P. F. Cheng, M. Levesque, R. Cornell, , E. Steingrimsson

This study shows MITF represses ECM and focal adhesion genes in melanoma, affecting cell morphology and matrix interactions, with reversible effects observed upon MITF knockdown.

bioRxiv · Jul 14, 2020Cancer Biology